Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets
New Delhi: Drug firm Zydus Cadila has recently said it has received the final nod from the US health regulator to market generic Lansoprazole tablets used for treating conditions caused by stomach acid.
The final approval from the United States Food and Drug Administration (USFDA) is to market Lansoprazole delayed-release orally disintegrating tablets in the strengths of 15 mg and 30 mg, Zydus Cadila said in a statement.
The product "will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad," it added. Lansoprazole tablets are used for the treatment of conditions such as ulcers, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome that are caused by stomach acid, Zydus Cadila said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd